Molecular Mechanisms Driving the Formation of Brain Metastases

被引:12
作者
Campbell, Bethany K. [1 ,2 ]
Gao, Zijie [1 ]
Corcoran, Niall M. [1 ,2 ,3 ,4 ,5 ]
Stylli, Stanley S. [1 ,6 ]
Hovens, Christopher M. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Surg, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Victorian Comprehens Canc Ctr, Ctr Canc Res, Parkville, Vic 3050, Australia
[3] Royal Melbourne Hosp, Dept Urol, Parkville, Vic 3050, Australia
[4] Western Hlth, Dept Urol, Footscray, Vic 3011, Australia
[5] Victorian Comprehens Canc Ctr, Melbourne, Vic 3000, Australia
[6] Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
brain metastases; genomics; secondary brain tumor; primary tumor; metastasis; BREAST-CANCER CELLS; MELANOMA; REVEALS; EVOLUTION; DIAGNOSIS; TISSUE;
D O I
10.3390/cancers14194963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Brain metastases are the most common brain tumor in adults and are associated with poor prognosis. The propensity of different solid tumors to metastasize varies greatly, with lung, breast, and melanoma primary tumors commonly leading to brain metastases, while other primaries such as prostate rarely metastasize to the brain. The molecular mechanisms that predispose and facilitate brain metastasis development are poorly understood. In this review, we present the current data on the genomic landscape of brain metastases that arise from various primary cancers and also outline potential molecular mechanisms that drive the formation of distant metastases in the brain. Targeted therapies for cancers have improved primary tumor response rates, but concomitantly, brain metastases (BM) have become the most common brain tumors in adults and are associated with a dismal prognosis of generally less than 6 months, irrespective of the primary cancer type. They most commonly occur in patients with primary breast, lung, or melanoma histologies; however, they also appear in patients with other primary cancers including, but not limited to, prostate cancer, colorectal cancer, and renal cell carcinoma. Historically, molecular biomarkers have normally been identified from primary tumor resections. However, clinically informative genomic alterations can occur during BM development and these potentially actionable alterations are not always detected in the primary tumor leading to missed opportunities for effective targeted therapy. The molecular mechanisms that facilitate and drive metastasis to the brain are poorly understood. Identifying the differences between the brain and other extracranial sties of metastasis, and between primary tumors and BM, is essential to improving our understanding of BM development and ultimately patient management and survival. In this review, we present the current data on the genomic landscape of BM from various primary cancers which metastasize to the brain and outline potential mechanisms which may play a role in promoting the formation of the distant metastases in the brain.
引用
收藏
页数:17
相关论文
共 71 条
[1]   Genetic mutations associated with lung cancer metastasis to the brain [J].
Aljohani, Hashim M. ;
Aittaleb, Mohamed ;
Furgason, John M. ;
Amaya, Peter ;
Deeb, Ayham ;
Chalmers, Jeffery J. ;
Bahassi, El Mustapha .
MUTAGENESIS, 2018, 33 (02) :137-145
[2]   Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies [J].
Bander, Evan D. ;
Yuan, Melissa ;
Carnevale, Joseph A. ;
Reiner, Anne S. ;
Panageas, Katherine S. ;
Postow, Michael A. ;
Tabar, Viviane ;
Moss, Nelson S. .
CANCER, 2021, 127 (12) :2062-2073
[3]   Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system [J].
Barnholtz-Sloan, JS ;
Sloan, AE ;
Davis, FG ;
Vigneau, FD ;
Lai, P ;
Sawaya, RE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2865-2872
[4]   Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers [J].
Berghoff, Anna S. ;
Schur, Sophie ;
Fuereder, Lisa M. ;
Gatterbauer, Brigitte ;
Dieckmann, Karin ;
Widhalm, Georg ;
Hainfellner, Johannes ;
Zielinski, Christoph C. ;
Birner, Peter ;
Bartsch, Rupert ;
Preusser, Matthias .
ESMO OPEN, 2016, 1 (02)
[5]   Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets [J].
Brastianos, Priscilla K. ;
Carter, Scott L. ;
Santagata, Sandro ;
Cahill, Daniel P. ;
Taylor-Weiner, Amaro ;
Jones, Robert T. ;
Van Allen, Eliezer M. ;
Lawrence, Michael S. ;
Horowitz, Peleg M. ;
Cibulskis, Kristian ;
Ligon, Keith L. ;
Tabernero, Josep ;
Seoane, Joan ;
Martinez-Saez, Elena ;
Curry, William T. ;
Dunn, Ian F. ;
Paek, Sun Ha ;
Park, Sung-Hye ;
McKenna, Aaron ;
Chevalier, Aaron ;
Rosenberg, Mara ;
Barker, Frederick G., II ;
Gill, Corey M. ;
Van Hummelen, Paul ;
Thorner, Aaron R. ;
Johnson, Bruce E. ;
Hoang, Mai P. ;
Choueiri, Toni K. ;
Signoretti, Sabina ;
Sougnez, Carrie ;
Rabin, Michael S. ;
Lin, Nancy U. ;
Winer, Eric P. ;
Stemmer-Rachamimov, Anat ;
Meyerson, Matthew ;
Garraway, Levi ;
Gabriel, Stacey ;
Lander, Eric S. ;
Beroukhim, Rameen ;
Batchelor, Tracy T. ;
Baselga, Jose ;
Louis, David N. ;
Getz, Gad ;
Hahn, William C. .
CANCER DISCOVERY, 2015, 5 (11) :1164-1177
[6]   Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study [J].
Cagney, Daniel N. ;
Martin, Allison M. ;
Catalano, Paul J. ;
Redig, Amanda J. ;
Lin, Nancy U. ;
Lee, Eudocia Q. ;
Wen, Patrick Y. ;
Dunn, Ian F. ;
Bi, Wenya Linda ;
Weiss, Stephanie E. ;
Haas-Kogan, Daphne A. ;
Alexander, Brian M. ;
Aizer, Ayal A. .
NEURO-ONCOLOGY, 2017, 19 (11) :1511-1521
[7]   Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors [J].
Chen, Clark C. ;
Rennert, Robert C. ;
Olson, Jeffrey J. .
NEUROSURGERY, 2019, 84 (03) :E195-E197
[8]   Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target [J].
Chen, Guo ;
Chakravarti, Nitin ;
Aardalen, Kimberly ;
Lazar, Alexander J. ;
Tetzlaff, Michael T. ;
Wubbenhorst, Bradley ;
Kim, Sang-Bae ;
Kopetz, Scott ;
Ledoux, Alicia A. ;
Gopal, Y. N. Vashisht ;
Pereira, Cristiano Goncalves ;
Deng, Wanleng ;
Lee, Ju-Seog ;
Nathanson, Katherine L. ;
Aldape, Kenneth D. ;
Prieto, Victor G. ;
Stuart, Darrin ;
Davies, Michael A. .
CLINICAL CANCER RESEARCH, 2014, 20 (21) :5537-5546
[9]   Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain [J].
Chen, Jinyu ;
Lee, Ho-Jeong ;
Wu, Xuefeng ;
Huo, Lei ;
Kim, Sun-Jin ;
Xu, Lei ;
Wang, Yan ;
He, Junqing ;
Bollu, Lakshmi R. ;
Gao, Guang ;
Su, Fei ;
Briggs, James ;
Liu, Xiaojing ;
Melman, Tamar ;
Asara, John M. ;
Fidler, Isaiah J. ;
Cantley, Lewis C. ;
Locasale, Jason W. ;
Zhang Weihua .
CANCER RESEARCH, 2015, 75 (03) :554-565
[10]   Integrative immunologic and genomic characterization of brain metastasis from ovarian/peritoneal cancer [J].
Choi, Youn Jin ;
Kim, Sang-Yeob ;
Park, Hyeon-Chun ;
Chung, Yeun-Jun ;
Hur, Soo Young ;
Lee, Sug Hyung .
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (08)